Home » Newsletters » BioWorld Science

BioWorld Science

July 22, 2022

View Archived Issues

NiKang Therapeutics patents new PROTACs for cancer

Genzyme discloses new CSF-1R inhibitors

Gilead Sciences synthesizes new PADI4 inhibitors

University of California presents new CYP3A4 inhibitors

MEKanistic Therapeutics identifies new PI3K and/or EGFR inhibitors

GATA1 c.616A>C mutation tied to thrombocytopenia due to platelet formation impairment

Inosine released by apoptotic brown adipocytes regulates thermogenic fat and counteracts obesity

PAN domain regulates binding and activation of the c-MET pathway and may be an anticancer target

Novel variants in genes HPS3, HPS5 and DTNBP1 linked to Hermansky-Pudlak syndrome

Preclinical characterization of novel antileishmanial agents

PharmaCyte begins pig study to support planned clinical trial of CypCaps for pancreatic cancer

FDA clears IND for Obsidian's TIL therapy OBX-115

Sosei and Cancer Research UK agree to advance EP4 antagonist HTL-0039732 into clinic

Oncogenic collagen allows cancer cells to evade immune response

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...